The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
Functional Neuroimaging in Depression: Longitudinal Study of PET Metabolism in Correlation With Changes in Attentional Bias, Autobiographical Memory, Future Fluency and Facial Recognition in Depressed Patients Treated With Escitalopram.
Study Start Date :
Actual Primary Completion Date :
Actual Study Completion Date :
Resource links provided by the National Library of Medicine
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
18 Years to 65 Years (Adult, Older Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Major Depression, Depressive episode, following DSM-IV criteria
MADRS-score > 25
Age: 18-65 yrs
Medication-free or anti-depressant wash-out 7 days (for fluoxetine: 6 weeks)
Lorazepam 1mg or zolpidem 10mg are allowed
Bipolar disorder, following DSM-IV criteria
Personality disorder, following DSM-IV criteria
Cognitive dysfunction due to trauma capitis or dementia
Women without contraceptive protection, with pregnancy or breast feeding
Pharmacological treatment or ingestion of substance that can influence cerebral perfusion less than a month before inclusion